Lucie Raskin: New FAERS Evidence Suggests Lower VTE Risk With Natural Estrogen COCs
Lucie Raskin, PhD student at University of Namur, shared on LinkedIn about a recent article she and her colleagues co-authored, adding:
”New publication accepted in the American Journal of Obstetrics and Gynecology.
Our disproportionality analysis of the FAERS database provides new evidence suggesting that combined oral contraceptives containing natural estrogens may represent safer options regarding venous thromboembolic risk.
Pleased to share this work with Marie Didembourg, Jean-Michel Dogné, Mitchell Creinin, Médéa Locuet.
Special thanks to my promotors Jonathan Douxfils and Charlotte Beaudart.”
Title: Venous Thromboembolism with Combined Oral Contraceptives Based on Estrogen and Progestin Content: A disproportionality analysis of the United States Food and Drug Administration Adverse Event Reporting System database
Authors: Lucie Raskin, Marie Didembourg, Jean-Michel Dogné, Médéa Locquet, Mitchell D. Creinin, Charlotte Beaudart, Jonathan Douxfils
Read the Full Article on American Journal of Obstetrics and Gynecology
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC